stockrowPACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
Follow PACS
Alert me
PACS Group, Inc. (PACS) Free cash flow
PACS Group, Inc.'s free cash flow for fiscal 2025 was $299.6M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $448.5M. Over the past ten years it has ranged from −$66.5M (fiscal 2021) to $302.4M (fiscal 2024); the current reading is higher than 80% of that period. PACS Group, Inc. ranks 8th of 50 Medical Care Facilities companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $299.6M | (0.93%) |
| FY2024 | $302.4M | 1,520.02% |
| FY2023 | $18.7M | (73.25%) |
| FY2022 | $69.8M | — |
| FY2021 | −$66.5M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $178.7M | 64.01% |
| Jun 2026 | $109.0M | (49.19%) |
| Mar 2026 | $214.5M | — |
| Dec 2025 | −$53.7M | — |
| 13 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $2.0B |
| DVA DaVita Inc. compare | $1.3B |
| UHS Universal Health Services, Inc. compare | $1.1B |
| ENSG The Ensign Group, Inc. compare | $509.9M |
| PACS PACS Group, Inc. | $448.5M |
| CHE Chemed Corporation compare | $296.8M |
| OPCH Option Care Health, Inc. compare | $281.7M |
| CON Concentra Group Holdings Parent, Inc. compare | $261.7M |
| LFST LifeStance Health Group, Inc. compare | $179.3M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on PACS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement